Distance-dependent magnetic resonance tuning (MRET) technology enables the sensing and quantitative imaging of biological targets in vivo, with the advantage of deep tissue penetration and fewer interactions with the surroundings as compared with those of fluorescence-based Förster resonance energy transfer. However, applications of MRET technology in vivo are currently limited by the moderate contrast enhancement and stability of T1-based MRET probes. Here we report a new two-way magnetic resonance tuning (TMRET) nanoprobe with dually activatable T1 and T2 magnetic resonance signals that is coupled with dual-contrast enhanced subtraction imaging. This integrated platform achieves a substantially improved contrast enhancement with minimal background signal and can be used to quantitatively image molecular targets in tumours and to sensitively detect very small intracranial brain tumours in patient-derived xenograft models. The high tumour-to-normal tissue ratio offered by TMRET in combination with dual-contrast enhanced subtraction imaging provides new opportunities for molecular diagnostics and image-guided biomedical applications.
This is a preview of subscription content, access via your institution
Open Access articles citing this article.
Nature Communications Open Access 26 December 2022
Journal of Nanobiotechnology Open Access 16 June 2022
Journal of Nanobiotechnology Open Access 19 May 2022
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Rent or buy this article
Prices vary by article type
Prices may be subject to local taxes which are calculated during checkout
The data that support the plots within this paper and other findings of this study are available from the corresponding author upon reasonable request.
The subtraction imaging was obtained in MATLAB R2013b software by using the following commands:
A = imread (‘D:T1WI’); B = imread (‘D: T2WI’); C = imsubtract (A, B); J = imcomplement c;
J, subtraction images of the T1- and T2-weighted imaging.
The last step involved the antiphase processing of subtraction images using MATLAB R2013b software.
Liu, G. L. et al. A nanoplasmonic molecular ruler for measuring nuclease activity and DNA footprinting. Nat. Nanotechnol. 1, 47–52 (2006).
Nguyen, A. W. & Daugherty, P. S. Evolutionary optimization of fluorescent proteins for intracellular FRET. Nat. Biotechnol. 23, 355–360 (2005).
Sönnichsen, C., Reinhard, B. M., Liphardt, J. & Alivisatos, A. P. A molecular ruler based on plasmon coupling of single gold and silver nanoparticles. Nat. Biotechnol. 23, 741–745 (2005).
Ma, Y. et al. A FRET sensor enables quantitative measurements of membrane charges in live cells. Nat. Biotechnol. 35, 363–370 (2017).
Schuler, B., Lipman, E. A. & Eaton, W. A. Probing the free-energy surface for protein folding with single-molecule fluorescence spectroscopy. Nature 419, 743–747 (2002).
Rizzo, M. A., Springer, G. H., Granada, B. & Piston, D. W. An improved cyan fluorescent protein variant useful for FRET. Nat. Biotechnol. 22, 445–449 (2004).
Biskup, C., Zimmer, T. & Benndorf, K. FRET between cardiac Na+ channel subunits measured with a confocal microscope and a streak camera. Nat. Biotechnol. 22, 220–224 (2004).
Jares-Erijman, E. A. & Jovin, T. M. FRET imaging. Nat. Biotechnol. 21, 1387–1395 (2003).
Choi, J. S. et al. Distance-dependent magnetic resonance tuning as a versatile MRI sensing platform for biological targets. Nat. Mater. 16, 537–542 (2017).
Mizukami, S. et al. Paramagnetic relaxation-based 19F MRI probe to detect protease activity. J. Am. Chem. Soc. 130, 794–795 (2008).
Mura, S., Nicolas, J. & Couvreur, P. Stimuli-responsive nanocarriers for drug delivery. Nat. Mater. 12, 991–1003 (2013).
Hong, R. et al. Glutathione-mediated delivery and release using monolayer protected nanoparticle carriers. J. Am. Chem. Soc. 128, 1078–1079 (2006).
Tam, N. C. M. et al. Porphyrin–lipid stabilized gold nanoparticles for surface enhanced Raman scattering based imaging. Bioconj. Chem. 23, 1726–1730 (2012).
Lovell, J. F. et al. Porphysome nanovesicles generated by porphyrin bilayers for use as multimodal biophotonic contrast agents. Nat. Mater. 10, 324–332 (2011).
Xue, X. et al. Trojan horse nanotheranostics with dual transformability and multifunctionality for highly effective cancer treatment. Nat. Commun. 9, 3653 (2018).
Zhou, Z. et al. T1–T2 dual-modal magnetic resonance imaging: from molecular basis to contrast agents. ACS Nano 11, 5227–5232 (2017).
Santra, S. et al. Gadolinium-encapsulating iron oxide nanoprobe as activatable NMR/MRI contrast agent. ACS Nano 6, 7281–7294 (2012).
Mørup, S., Hansen, M. F. & Frandsen, C. Magnetic interactions between nanoparticles. Beilstein J. Nanotechnol. 1, 182–190 (2010).
Köseoğlu, Y., Yıldız, F., Kim, D. K., Muhammed, M. & Aktaş, B. EPR studies on Na-oleate coated Fe3O4 nanoparticles. Phys. Status Solidi C 1, 3511–3515 (2004).
Kuch, W. et al. Three-dimensional noncollinear antiferromagnetic order in single-crystalline FeMn ultrathin films. Phys. Rev. Lett. 92, 017201 (2004).
Webb, M. R., Ash, D. E., Leyh, T. S., Trentham, D. R. & Reed, G. H. Electron paramagnetic resonance studies of Mn(ii) complexes with myosin subfragment 1 and oxygen 17-labeled ligands. J. Biol. Chem. 257, 3068–3072 (1982).
Bulte, J. W., Brooks, R. A., Moskowitz, B. M., Bryant, L. H. Jr. & Frank, J. A. Relaxometry and magnetometry of the MR contrast agent MION-46L. Magn. Reson. Med. 42, 379–384 (1999).
Li, Y. et al. Probing of the assembly structure and dynamics within nanoparticles during interaction with blood proteins. ACS Nano 6, 9485–9495 (2012).
Li, Y. et al. Well-defined, reversible disulfide cross-linked micelles for on-demand paclitaxel delivery. Biomaterials 32, 6633–6645 (2011).
Li, Y., Xiao, K., Zhu, W., Deng, W. & Lam, K. S. Stimuli-responsive cross-linked micelles for on-demand drug delivery against cancers. Adv. Drug Deliv. Rev. 66, 58–73 (2014).
Maeda, H. et al. Effective treatment of advanced solid tumors by the combination of arsenic trioxide and l-buthionine-sulfoximine. Cell Death Differ. 11, 737–746 (2004).
Pileblad, E., Magnusson, T. & Fornstedt, B. Reduction of brain glutathione by l‐buthionine sulfoximine potentiates the dopamine‐depleting action of 6‐hydroxydopamine in rat striatum. J. Neurochem. 52, 978–980 (1989).
Zheng, X. et al. Successively activatable ultrasensitive probe for imaging tumour acidity and hypoxia. Nat. Biomed. Eng. 1, 0057 (2017).
Hori, S. S., Tummers, W. S. & Gambhir, S. S. Cancer diagnostics: on-target probes for early detection. Nat. Biomed. Eng. 1, 0062 (2017).
Li, Y. et al. A smart and versatile theranostic nanomedicine platform based on nanoporphyrin. Nat. Commun. 5, 4712 (2014).
Kato, J. et al. Disulfide cross-linked micelles for the targeted delivery of vincristine to B-cell lymphoma. Mol. Pharm. 9, 1727–1735 (2012).
Xiao, K. et al. Disulfide cross-linked micelles of novel HDAC inhibitor thailandepsin A for the treatment of breast cancer. Biomaterials 67, 183–193 (2015).
Wang, Z. et al. Active targeting theranostic iron oxide nanoparticles for MRI and magnetic resonance-guided focused ultrasound ablation of lung cancer. Biomaterials 127, 25–35 (2017).
Zhang, Z. et al. Facile synthesis of folic acid-modified iron oxide nanoparticles for targeted MR imaging in pulmonary tumor xenografts. Mol. Imaging Biol. 18, 569–578 (2016).
We thank financial support from the National Institutes of Health (NIH)/National Cancer Institute (R01CA199668), NIH/Eunice Kennedy Shriver National Institute of Child Health and Human Development (R01HD086195), UC Davis Comprehensive Cancer Center Support Grant (CCSG) awarded by the National Cancer Institute (NCI P30CA093373) and National Science Foundation (NSF) (ECCS-1611424 and ECCS-1933527). The acquisition of a magnetic property measurements system (MPMS3) at Georgetown University was supported by the NSF (DMR-1828420).
Y.L., X.X. and Z.W. are the co-inventors on the pending patent application filed by the Regents of the University of California on the TMRET nanotechnology and DESI.
Peer review information Nature Nanotechnology thanks Jeff Bulte, John Waterton and the other, anonymous, reviewer(s) for their contribution to the peer review of this work.
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
About this article
Cite this article
Wang, Z., Xue, X., Lu, H. et al. Two-way magnetic resonance tuning and enhanced subtraction imaging for non-invasive and quantitative biological imaging. Nat. Nanotechnol. 15, 482–490 (2020). https://doi.org/10.1038/s41565-020-0678-5
This article is cited by
Doping engineering of iron oxide nanoparticles towards high performance and biocompatible T1-weighted MRI contrast agents
Rare Metals (2023)
Dual-ratiometric magnetic resonance tunable nanoprobe with acidic-microenvironment-responsive property to enhance the visualization of early tumor pathological changes
Nano Research (2023)
Science China Chemistry (2023)
Nano Research (2023)
Journal of Nanobiotechnology (2022)